Lucy Shen is an Ophthalmology physician affiliated with Massachusetts Eye and Ear Infirmary. OpenAlex indexes 154 publications with 2,937 citations (h-index 28).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
243 Charles St
Boston, MA 02114
Telephone
617-573-4169Registry record last updated 8 Apr 2009.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20251 payment
- ABBVIE INC.Program year20242 payments
- ABBVIE INC.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
84.6%Prostaglandin Analog31.1%Latanoprost82%Lumigan8%Tafluprost5%Travoprost3%Zioptan2%Part D<11 patientsCarbonic Anhydrase Inhibitor27.5%Dorzolamide-Timolol64%Dorzolamide Hcl19%Brinzolamide8%Simbrinza4%Acetazolamide2%Azopt2%Acetazolamide Er1%Part D<11 patients+ 6 more classes in this area
Cardiovascular
9.6%Beta blocker9.6%Timolol Maleate100%Part D≥112 patientsAnti-infectives
3%Fluoroquinolone Antibacterial3%Moxifloxacin100%Part D≥80 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2021–2026 per NIH RePORTER. The latest:
- Innate and Adaptive Immunity in the Pathogenesis of Glaucoma
Schepens Eye Research Institute
FY2026$834,935R01EY031696 - Innate and Adaptive Immunity in the Pathogenesis of Glaucoma
Schepens Eye Research Institute
FY2025$610,152R01EY031696 - Innate and Adaptive Immunity in the Pathogenesis of Glaucoma
Schepens Eye Research Institute
FY2024$717,827R01EY031696
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Harvard Glaucoma Fairness: A Retinal Nerve Disease Dataset for Fairness Learning and Fair Identity Normalization
IEEE Transactions on Medical Imaging
2024 - Artifact-Tolerant Clustering-Guided Contrastive Embedding Learning for Ophthalmic Images in Glaucoma
IEEE Journal of Biomedical and Health Informatics
2023 - Expanding relationship science to unpartnered singles: What predicts life satisfaction?
Frontiers in Psychology
2022 - Restoration of Vision in Severe, Cicatricial, Ocular Surface Disease With the Boston Keratoprosthesis Type II
American Journal of Ophthalmology
2022 - Paired Optic Nerve Microvasculature and Nailfold Capillary Measurements in Primary Open-Angle Glaucoma
Translational Vision Science & Technology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
John Kempen, MD
Massachusetts Eye and Ear Infirmary
Neil Bhattacharyya, MD, FACS
Massachusetts Eye and Ear Infirmary
Demetrios Vavvas, MD, PhD
Massachusetts Eye and Ear Infirmary
Evangelos Gragoudas, MD
Massachusetts Eye and Ear Infirmary
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”